SUBSCRIBE
SUBSCRIBE

Ensoma

NEWS
Illustration of hand holding trophy with people coming out of trophy and celebrating
Job Trends
BioSpace Announces 2025 Best Places to Work in Biopharma
BioSpace has named 50 biopharma companies to its 2025 Best Places to Work list, including Moderna and Sutro Biopharma, whose executives share what makes their organizations special.
November 12, 2024
 · 
6 min read
 · 
Angela Gabriel
Business
Top Life Sciences Startups to Watch in 2022
BioSpace is proud to present its NextGen Bio “Class of 2022,” a list of up-and-coming life sciences companies in North America that recently launched.
January 4, 2022
 · 
19 min read
 · 
Heather McKenzie
IN THE PRESS
Press Releases
Ensoma Announces Clearance of U.K. Clinical Trial Authorization Application for EN-374, First In Vivo HSC-Directed Gene Insertion Therapy
December 11, 2025
 · 
3 min read
Press Releases
Profluent Bio Announces Strategic Collaboration with Ensoma to Develop AI-Designed Base Editors for In Vivo Hematopoietic Stem Cell Therapies
December 10, 2025
 · 
2 min read
Press Releases
Ensoma Announces First Patient Dosed in Phase 1/2 Clinical Trial of EN-374 for Treatment of X-CGD
December 2, 2025
 · 
4 min read
Press Releases
Ensoma Presents Preclinical Data Demonstrating Potential of In Vivo, HSC-derived CAR-M, NK, and T Platform for Solid Tumors at SITC 2025
November 5, 2025
 · 
3 min read
Press Releases
Ensoma to Present New Preclinical Data at the Society for Immunotherapy of Cancer Annual Meeting
October 6, 2025
 · 
1 min read
Press Releases
Ensoma Announces $53 Million Financing to Support Key Clinical Milestones for EN-374 and Continued Development of In Vivo Hematopoietic Stem Cell Engineering Pipeline
September 23, 2025
 · 
3 min read
Press Releases
Ensoma Announces FDA Clearance of IND Application for First In Vivo HSC-Directed Gene Insertion Therapy
May 12, 2025
 · 
4 min read
Press Releases
Ensoma to Present Preclinical Data and Manufacturing Advancements for In Vivo HSC Engineering Platform to Treat Cancer, Immune Disorders and Genetic Diseases at ASGCT 28th Annual Meeting
April 29, 2025
 · 
5 min read
Press Releases
Ensoma Receives Rare Pediatric Disease and Orphan Drug Designations for EN-374 for Treatment of Chronic Granulomatous Disease
February 13, 2025
 · 
3 min read
Press Releases
Ensoma Unveils Three Programs Leveraging In Vivo Hematopoietic Stem Cell Engineering Platform to Target Genetic, Immune and Oncological Diseases
November 6, 2024
 · 
7 min read
Load More
AWARDS
  • 2024 Best Places to Work - Transparent
  • 2025 BPTW Badge - RBG.png
JOBS